GAP-Net site USF Health has received a grant from the NIH to study a computerized brain training exercise, and if it can reduce the disk of Alzheimer’s disease and other dementias. The National Institutes of Health (NIH) has awarded the University of South Florida (USF) total expected funds of $44.4 million over the next five […]
GAP-Net Site KU ADC has received over $1.3 million to research how exercise supports the brain as humans age. TOPEKA, Kan. (WIBW) – The University of Kansas Alzheimer’s Disease Center has received over $1 million to research how exercise could prevent Alzheimer’s. Senator Roger Marshall (R-Kan.) says the University of Kansas Alzheimer’s Disease Center has […]
GAP-Net site Kansas University ADC was granted $4.3 million from the NIH to elevate dementia care in Kansas communities. Dementia researchers are convinced the path to beating back the life-robbing disease goes directly through clinical trials fueled by research volunteers willing to join the battle. That’s why the experts at the University of Kansas Alzheimer’s Disease […]
GAP President John Dwyer speaks about GAP’s participation in the original Trailblazer trial, and our goals for TRAILBLAZER-ALZ 2. It has been clear for a while that anti-amyloid antibodies can sweep plaque from the brain, but until now the question of whether this slows cognitive decline has remained hotly contended. Despite some positive signals from […]
GAP-Net site Knight ADRC at Washington University in St. Louis received two grants to determine whether driving changes can identify people with mild and very mild cognitive impairment, and maybe even identify people in the earliest stage of Alzheimer’s disease. Every day in the U.S. in 2018, motor vehicle crashes killed more than 20 people […]
GAP-Net Site, The Cognitive and Research Center of New Jersey, talks about their participation in the GREEN MEMORY trial. The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3, multi-center clinical trial that is actively recruiting participants. Oligomannate, a drug made from seaweed […]
GAP President John Dwyer spoke about the Green Valley clinical trial’s success in China, which is now being tested in North America. A new drug extracted from seaweed and inspired by traditional Chinese medicine has come to the United States, where researchers hope it will provide the breakthrough in Alzheimer’s treatment that has eluded us […]
GAP Chairman, George Vradenburg, and The Women’s Alzheimer’s Movement founder, Maria Shriver, co-wrote a piece on what the Biden Administration needs to do to start fulfilling their promises made to Alzheimer’s patients and researchers. No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden. The commitment and […]
GAP-Net site Clarity Clinical Research issued the first treatment to volunteer Mark Cornue in the GREEN MEMORY study. Last week, Clarity Clinical Research administered the first research treatment in the world for the Green Memory study to Mark Cornue, a local Jordan resident and Alzheimer’s patient. The Green Memory study is a noninvasive Alzheimer’s disease clinical trial […]
GAP-Net site Kerwin Medical Center’s Citizen Scientist, Dominic Morello, a caregiver for his father with Alzheimer’s, wrote an Op-Ed on how this generations Alzheimer’s patients can make the disease a thing of the past. There are more than 100 potential Alzheimer’s treatments in the pipeline, but the majority of clinical trials for potential Alzheimer’s therapies are delayed due to enrollment […]